Cantley Lewis Clayton Jr. 4

4 · AGIOS PHARMACEUTICALS INC · Filed Oct 18, 2017

Form 4

Period: 2017-10-16

Director

Transactions

Sale
Common stock
[F1][F2]
2017-10-16$71.09/sh−1,000$71,090→ 84,394 total
Sale
Common stock
[F1][F2][F3]
2017-10-16$71.09/sh−1,000$71,090→ 84,434 total(indirect: See footnote)
Sale
Common stock
[F1][F4]
2017-10-17$71.10/sh−1,000$71,100→ 83,394 total
Sale
Common stock
[F1][F4][F3]
2017-10-17$71.10/sh−1,000$71,100→ 83,434 total(indirect: See footnote)

Holdings

Footnotes (6)

[F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
[F2]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $70.58 to $71.83. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F3]Shares held by Vicki Lee Sato, who is the reporting person's spouse.
[F4]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $70.71 to $71.51. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F5]Shares held by grantor retained annuity trusts for the benefit of the reporting person and his two children, of which the reporting person is trustee and sole annuitant.
[F6]Shares held by grantor retained annuity trusts for the benefit of the reporting person's spouse and their two children, of which the reporting person's spouse is trustee and sole annuitant.

Signature

/s/ William Cook, as Attorney-in-fact for Lewis C. Cantley Jr.|2017-10-18

Documents

2 files